It is well established that quiescence or dormancy preserves the self-renewal and long-term reconstituting potential of long-term HSCs (LT-HSC). HSCs that are quiescent give rise to much higher reconstitution than proliferating HSCs in transplant recipients, and signals that drive HSCs into proliferation cycle often lead to HSC differentiation and exhaustion. However, the mechanisms that coordinate HSC quiescence, proliferation and differentiation remains to be investigated. Recently, we and others reported that protein homeostasis at endoplasmic reticulum (ER) plays important role in preserving HSC functions under stressed condition. However, it remains to be investigated whether protein quality control is important for HSCs under steady state, when the majority of HSCs remain in a deeply dormant state with profoundly reduced protein synthesis rate and metabolic activity. ER associated degradation (ERAD) is a critical component of protein homeostasis, and ensures protein quality control by degrading inappropriately folded or assembled proteins in ER. ERAD complexes recognize misfolded proteins in ER and translocate them to cytosol for proteasomal degradation. Our preliminary studies indicate that protein quality control via ERAD governs HSC quiescence and self-renewal. The Sel1L/Hrd1 ERAD genes are enriched in the quiescent and inactive HSCs, and conditional knockout of Sel1L in hematopoietic tissues drives HSCs to hyper-proliferation, which leads to complete loss of HSC self-renewal and HSC depletion. ERAD deficiency via Sel1L knockout induces a non-apoptotic ER stress and activates all three main pathways of unfolded protein response (UPR). Furthermore, we found that mTOR signaling is activated in Sel1L knockout HSCs and inhibition of mTOR via rapamycin rescues Sel1L knockout-induced HSC defects. We therefore hypothesize that Sel1L maintains HSC quiescence and self-renewal by restricting mTORC activity. Here, we propose three aims to determine the mechanism by which ERAD modulates mTOR signaling to preserve HSC quiescence and self-renewal: 1) Determine the role of Akt/mTOR signaling branches in Sel1L-mediated HSC regulation; 2) Dissect the interaction of ERAD and UPR signaling; and 3) Determine the role of Rheb in ERAD deficiency-induced HSC dysregulation. These studies will establish Sel1L/Hrd1 ERAD as the master regulator of HSC quiescence, and provide novel insights into how protein quality control systems coordinate with proliferation signaling pathways to determine HSC fate.

Public Health Relevance

Dysregulation of blood stem cells leads to failure of blood cell production. We identified a new pathway, endoplasmic reticulum associated degradation (ERAD), as a critical regulator to maintain blood stem cell functions. The proposed studies will identify the mechanism by which ERAD promotes blood stem cell functions, and provide new insights into how blood stem cell functions are maintained, which potentially can inform novel approach for blood cell regeneration.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Bai, C Brian
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Internal Medicine/Medicine
Schools of Medicine
Ann Arbor
United States
Zip Code